Get the Stockscreener App
226.35
1.54%
-3.53
After Hours:
226.35
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cardinal Health Inc stock is traded at $226.35, with a volume of 2.40M.
It is down -1.54% in the last 24 hours and up +3.83% over the past month.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
See More
Previous Close:
$229.88
Open:
$228
24h Volume:
2.40M
Relative Volume:
1.33
Market Cap:
$53.26B
Revenue:
$244.67B
Net Income/Loss:
$1.68B
P/E Ratio:
32.57
EPS:
6.9487
Net Cash Flow:
$5.51B
1W Performance:
+0.17%
1M Performance:
+3.83%
6M Performance:
+50.34%
1Y Performance:
+75.22%
1-Day Range:
$222.29
$228.98
1-Week Range:
$222.29
$233.60
52-Week Range:
$120.72
$233.60
Cardinal Health Inc Stock (CAH) Company Profile
Name
Cardinal Health Inc
Sector
Industry
Phone
(614) 757-3033
Address
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
226.35 | 54.09B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
MCK
Mckesson Corporation
|
995.69 | 121.38B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
371.44 | 72.49B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
HSIC
Henry Schein Inc
|
80.21 | 9.58B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.4414 | 1.12B | 2.22M | -5.63M | -1.68M | -0.24 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Upgrade | Citigroup | Neutral → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Jun-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-05-25 | Upgrade | Jefferies | Hold → Buy |
| Jan-08-25 | Upgrade | TD Cowen | Hold → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-06-25 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-13-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Upgrade | Argus | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Underweight |
| Jul-10-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-23 | Initiated | Citigroup | Neutral |
| Feb-03-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-04-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| May-26-22 | Downgrade | Barclays | Overweight → Equal Weight |
| May-18-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Apr-12-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Aug-06-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Aug-05-21 | Downgrade | BofA Securities | Buy → Underperform |
| May-10-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-21 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Sep-25-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Jul-20-20 | Upgrade | Guggenheim | Neutral → Buy |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-20-20 | Upgrade | BofA/Merrill | Underperform → Buy |
| Feb-12-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-16-19 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-27-19 | Downgrade | Argus | Buy → Hold |
| Aug-20-19 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-18-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Nov-16-18 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Apr-02-18 | Upgrade | Argus | Hold → Buy |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Underperform |
| Jan-05-18 | Initiated | Evercore ISI | In-line |
View All
Cardinal Health Inc Stock (CAH) Latest News
Cardinal Health, Inc. $CAH Shares Acquired by Victory Capital Management Inc. - MarketBeat
Strive Asset Management LLC Takes Position in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Stock in 2026: Why Analysts Set a $248 Mean Target - TIKR.com
Quantbot Technologies LP Reduces Stake in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health (NYSE:CAH) Hits New 12-Month High Following Analyst Upgrade - MarketBeat
Should Value Investors Buy Cardinal Health (CAH) Stock? - Yahoo Finance Australia
Cardinal Health stock hits all-time high at 232.01 USD By Investing.com - Investing.com Canada
Leerink Partners Adjusts Price Target on Cardinal Health to $275 From $268, Maintains Outperform Rating - marketscreener.com
Cardinal Health, Inc. (CAH) Investor Outlook: Strong Growth Potential With 8.54% Upside - DirectorsTalk Interviews
Erste Asset Management GmbH Reduces Position in Cardinal Health, Inc. $CAH - MarketBeat
Andra AP fonden Decreases Position in Cardinal Health, Inc. $CAH - MarketBeat
Sierra Summit Advisors LLC Purchases New Stake in Cardinal Health, Inc. $CAH - MarketBeat
Finemark National Bank & Trust Buys Shares of 66,996 Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health, Inc. (CAH): A Bull Case Theory - Yahoo Finance
Cardinal Health, Inc. $CAH Shares Purchased by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Global Medical Device Cleaning Market Poised for Strong Growth as Infection Control Mandates and Reprocessing Technologies Accelerate Adoption: Verified Market Research® - GlobeNewswire Inc.
Westfield Capital Management Co. LP Takes Position in Cardinal Health, Inc. $CAH - MarketBeat
TD Asset Management Inc Buys 10,265 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Banco Santander S.A. Raises Stake in Cardinal Health, Inc. $CAH - MarketBeat
3 Big Winners from the 2025 Q4 Earnings Cycle: CAH, BOOT, PLTR - TradingView
Intech Investment Management LLC Has $41.48 Million Holdings in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health, Inc. (NYSE:CAH) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Workers say Cardinal Health attacks union organizers and allows sexual harassment - People's World
March 2027 Options Now Available For Cardinal Health (CAH) - Nasdaq
Wall Street Analysts Are Neutral on Top Healthcare Picks - The Globe and Mail
Cardinal Health (CAH) Sees Continued Support with Analysts Raisi - GuruFocus
Biosimilar drugs saved more than $56B, Cardinal Health says - Stock Titan
Cardinal Health, Inc. $CAH Shares Bought by Counterpoint Mutual Funds LLC - MarketBeat
Citigroup Inc. Purchases 4,962 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health, Inc. (CAH) Stock Analysis: Steady Growth And A 10% Upside Potential - DirectorsTalk Interviews
Barclays Adjusts Cardinal Health Price Target to $258 From $243, Maintains Overweight Rating - marketscreener.com
Cardinal Health and FMC Corporation have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Bull of the Day: Cardinal Health (CAH) - Zacks Investment Research
Kovitz Investment Group Partners LLC Raises Stock Position in Cardinal Health, Inc. $CAH - MarketBeat
Tredje AP fonden Buys 5,808 Shares of Cardinal Health, Inc. $CAH - MarketBeat
HighTower Advisors LLC Cuts Stock Holdings in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Inc.: Why This ‘Boring’ Stock Suddenly Matters to You - AD HOC NEWS
Wells Fargo Raises Outlook on Cardinal Health (CAH), Cites Broad Business Strength - Finviz
Jupiter Asset Management Ltd. Acquires Shares of 298,883 Cardinal Health, Inc. $CAH - MarketBeat
Public Sector Pension Investment Board Purchases 12,003 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Cumberland Partners Ltd Takes Position in Cardinal Health, Inc. $CAH - MarketBeat
Zacks Investment Ideas feature highlights Cardinal Health and Palantir - Nasdaq
Q4 Earnings: These Buy-Rated Stocks Crushed Expectations - Finviz
$3.8 Billion Negative Pressure Wound Therapy (NPWT) Devices - GlobeNewswire
$3.8 Billion Negative Pressure Wound Therapy (NPWT) Devices Market Assessment, 2030Featuring Solventum, Smith+Nephew, Cardinal Health, Molnlycke Health Care, ConvaTec Group and Other Key Players - Yahoo Finance
NEOS Investment Management LLC Buys 19,639 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Skandinaviska Enskilda Banken AB publ Sells 13,909 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Stock Is Trading Near Record Levels: Here’s the Path to $467 - TIKR.com
Cardinal Health Inc (NYSE:CAH) Shows Strong Growth and Technical Momentum - ChartMill
Vanguard Group Inc. Has $4.84 Billion Stock Position in Cardinal Health, Inc. $CAH - MarketBeat
Zacks.com featured highlights include Boot Barn, Brinker International, Tapestry and Cardinal Health - Yahoo Finance
Cardinal Health Inc Stock (CAH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.32%
10.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):